171 related articles for article (PubMed ID: 33973957)
21. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of 24-hour blood pressure in pregnancy.
Bellomo G; Narducci PL; Rondoni F; Pastorelli G; Stangoni G; Angeli G; Verdecchia P
JAMA; 1999 Oct; 282(15):1447-52. PubMed ID: 10535435
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients.
de la Sierra A; Vinyoles E; Banegas JR; Segura J; Gorostidi M; de la Cruz JJ; Ruilope LM
J Hypertens; 2017 Dec; 35(12):2388-2394. PubMed ID: 28723880
[TBL] [Abstract][Full Text] [Related]
24. Are the cardiovascular outcomes of participants with white-coat hypertension poor compared to those of participants with normotension? A systemic review and meta-analysis.
Fujiwara T; Matsumoto C; Asayama K; Ohkubo T; Hoshide S
Hypertens Res; 2019 Jun; 42(6):825-833. PubMed ID: 30971805
[TBL] [Abstract][Full Text] [Related]
25. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study.
Omboni S; Aristizabal D; De la Sierra A; Dolan E; Head G; Kahan T; Kantola I; Kario K; Kawecka-Jaszcz K; Malan L; Narkiewicz K; Octavio JA; Ohkubo T; Palatini P; Siègelovà J; Silva E; Stergiou G; Zhang Y; Mancia G; Parati G;
J Hypertens; 2016 Nov; 34(11):2187-98. PubMed ID: 27512964
[TBL] [Abstract][Full Text] [Related]
26. Development of preeclampsia in pregnant women with white-coat hypertension: a systematic review and meta-analysis.
Hadizadeh S; Shahmohamadi E; Khezerlouy-Aghdam N; Heidary L; Tarafdari A; Hantoushzadeh S; Ayati A; Foroutani L; Ahmadi-Tafti H; Mohseni-Badalabadi R; Vahidi H; Hadizadeh A; Mousavi S
Arch Gynecol Obstet; 2024 Mar; 309(3):929-937. PubMed ID: 37792010
[TBL] [Abstract][Full Text] [Related]
27. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension.
Mancia G; Facchetti R; Grassi G; Bombelli M
Hypertension; 2015 Aug; 66(2):437-44. PubMed ID: 26056342
[TBL] [Abstract][Full Text] [Related]
28. White-Coat and Reverse White-Coat Effects Correlate with 24-h Pulse Pressure and Systolic Blood Pressure Variability in Children and Young Adults.
Fujita H; Matsuoka S; Awazu M
Pediatr Cardiol; 2016 Feb; 37(2):345-52. PubMed ID: 26481222
[TBL] [Abstract][Full Text] [Related]
29. [White-coat hypertension].
Yamashita S
Nihon Rinsho; 2014 Aug; 72(8):1410-4. PubMed ID: 25167744
[TBL] [Abstract][Full Text] [Related]
30. [24-hour blood pressure in normotensive elderly women and elderly women with white-coat hypertension].
Hekman PR; Barbisan JN; Menezes HS; Antonello V
Arq Bras Cardiol; 2010 Apr; 94(4):431-7. PubMed ID: 20339820
[TBL] [Abstract][Full Text] [Related]
31. High Prevalence of Hypertension in a Danish Population Telemedical Home Measurement of Blood Pressure in Citizens Aged 55-64 Years in Holstebro County.
Hoffmann-Petersen N; Lauritzen T; Bech JN; Pedersen EB
Am J Hypertens; 2016 Apr; 29(4):439-47. PubMed ID: 26208671
[TBL] [Abstract][Full Text] [Related]
32. Target organ damage in "white coat hypertension" and "masked hypertension".
Kotsis V; Stabouli S; Toumanidis S; Papamichael C; Lekakis J; Germanidis G; Hatzitolios A; Rizos Z; Sion M; Zakopoulos N
Am J Hypertens; 2008 Apr; 21(4):393-9. PubMed ID: 18292757
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic criteria of white coat hypertension (WCH): consequences for the implications of WCH for target organs.
Pose-Reino A; Rodríguez-Fernández M; López-Barreiro L; Coleman IC; Estévez-Nuñez JC; Méndez-Naya I
Blood Press; 2002; 11(3):144-50. PubMed ID: 12126260
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Masked and White-Coat Hypertension in Pre-Hypertensive and Stage 1 Hypertensive patients with the use of TeleMRPA.
Barroso WKS; Feitosa ADM; Barbosa ECD; Miranda RD; Brandão AA; Vitorino PVO; Ribeiro LPS; Gomes MM
Arq Bras Cardiol; 2019 Nov; 113(5):970-975. PubMed ID: 31432980
[TBL] [Abstract][Full Text] [Related]
35. Masked and white coat hypertension, the double trouble of large arteries: A systematic review and meta-analysis.
Antza C; Vazakidis P; Doundoulakis I; Bouras E; Haidich AB; Stabouli S; Kotsis V
J Clin Hypertens (Greenwich); 2020 May; 22(5):802-811. PubMed ID: 32356941
[TBL] [Abstract][Full Text] [Related]
36. White coat hypertension in childhood: evidence for end-organ effect.
Kavey RE; Kveselis DA; Atallah N; Smith FC
J Pediatr; 2007 May; 150(5):491-7. PubMed ID: 17452222
[TBL] [Abstract][Full Text] [Related]
37. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
[TBL] [Abstract][Full Text] [Related]
38. White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty.
Abolbashari M
Curr Cardiol Rep; 2018 Mar; 20(4):25. PubMed ID: 29520630
[TBL] [Abstract][Full Text] [Related]
39. Possible cardiovascular risks of white coat hypertension: updated.
Chrysant SG
Postgrad Med; 2023 Jun; 135(5):466-471. PubMed ID: 37161879
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
